Article

Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe…

Journal of Asthma and Allergy · 2022 · Bachert C, Khan AH, Hopkins C, Blaiss MS, Soler ZM, Nash S, Siddiqui S, Praestgaard A, Deniz Y, Rowe PJ, Jacob-Nara JA

Key facts

Title Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP
First author Bachert C, Khan AH, Hopkins C, Blaiss MS, Soler ZM, Nash S, Siddiqui S, Praestgaard A, Deniz Y, Rowe PJ, Jacob-Nara JA
Journal Journal of Asthma and Allergy
Published May 4, 2022
DOI 10.2147/JAA.S355391
Devices mentioned K082750, K121351, K130354, K914919
Product codes mentioned GCJ, GEI, HTF, LRC, LYA, MMO, OLL

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature